Seminars in Pediatric Neurology
Volume 12, Issue 3 , Pages 152-158 , September 2005

The Dystroglycanopathies: The New Disorders of O-Linked Glycosylation

  • Paul T. Martin

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Paul T. Martin, Ph.D., Center for Gene Therapy, Columbus Children’s Research Institute, Departments of Pediatrics and Neurology, Ohio State University College of Medicine and Public Health, 700 Children’s Drive, Columbus, OH 43205.

References 

  1. Marth JD . O-glycans . In:  Varki A ,  Cummings R ,  Esko J , et al. editor. Essentials of Glycobiology . Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1999;
  2. Hennet T , Hagan FK , Tabak LA , et al.   T-cell-specific deletion of a polypeptide N-acetylgalactosaminyl-transferase gene by site-specific recombination . Proc Natl Acad Sci U S A . 1995;92:12070–12074
  3. Freeze H . Degradation and turnover of glycans . In:  Varki A ,  Cummings R ,  Esko J , et al. editor. Essentials of Glycobiology . Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press; 1999;
  4. Shi S , Stanley P . Protein O-fucosyltransferase 1 is an essential component of Notch signaling pathways . Proc Natl Acad Sci U S A . 2003;100:5234–5239
  5. Shafi R , Iyer SP , Ellies LG , et al.   The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny . Proc Natl Acad Sci U S A . 2000;97:5735–5739
  6. Wang Y , Shao L , Shi S , et al.   Modification of epidermal growth factor-like repeats with O-fucose. Molecular cloning and expression of a novel GDP-fucose protein O-fucosyltransferase . J Biol Chem . 2001;276:40338–40345
  7. Slawson C , Hart GW . Dynamic interplay between O-GlcNAc and O-phosphate:the sweet side of protein regulation . Curr Opin Struct Biol . 2003;13:631–636
  8. Kobayashi K , Nakahori Y , Miyake M , et al.   An ancient retrotransposonal insertion causes Fukuyama-type congenital muscular dystrophy . Nature . 1998;394:388–392
  9. Hayashi YK , Ogawa M , Tagawa K , et al.   Selective deficiency of alpha dystroglycan in Fukuyama-type congenital muscular dystrophy . Neurology . 2001;57:115–121
  10. Brockington M , Blake DJ , Prandini P , et al.   Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha 2 deficiency and abnormal glycosylation of alpha dystroglycan . Am J Hum Genet . 2001;69:1198–1209
  11. Brockington M , Yuva Y , Prandini P , et al.   Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C . Hum Mol Genet . 2001;10:2851–2859
  12. Longman C , Brockington M , Torelli S , et al.   Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan . Hum Mol Genet . 2003;12:2853–2861
  13. Grewal PK , Holzfeind PJ , Bittner RJ , et al.   Mutant glycosyltransferase and altered glycosylation of alpha dystroglycan in the myodystrophy mouse . Nat Genet . 2001;28:151–154
  14. Yoshida A , Kobayashi K , Manya H , et al.   Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1 . Dev Cell . 2001;1:717–724
  15. Manya H , Sakai K , Kobayashi K , et al.   Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease . Biochem Biophys Res Commun . 2003;306:93–97
  16. Beltran-Valero de Bernabe D , Currier S , Steinbrecher A , et al.   Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome . Am J Hum Genet . 2002;71:1033–1043
  17. Van Reeuwijk J , Janssen M , van den Elzen C , et al.   POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker Warburg syndrome . J Med Genet . 2005; (Epub ahead of print)
  18. Beltran Valero de Bernabe D , van Bokhovern H , van Beusenkom E , et al.   A homozygous nonsense mutations in the fukutin gene causes Walker-Warburg syndrome phenotype . J Med Genet . 2003;40:835–838
  19. Beltran Valero de Bernabe D , Voit T , Longman C , et al.   Mutations in the FKRP gene can cause muscle eye brain disease and Walker Warburg syndrome . J Med Genet . 2004;41:e61
  20. Taniguchi K , Kobayashi K , Saito K , et al.   Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease . Hum Mol Genet . 2003;12:527–534
  21. Jimenez-Mallebrera C , Brown SC , Sewry CA , et al.   Congenital muscular dystrophy:molecular and cellular aspects . Cell Mol Life Sci . 2005;62:809–823
  22. Van Reeuwijk J , Brunner HG , van Bokhoven H . Glyc-O-genetics of Walker-Warburg syndrome . Clin Genet . 2005;67:281–289
  23. Martin PT , Freeze HH . Glycobiology of neuromuscular disorders . Glycobiology . 2003;13:67R–75R
  24. Topaloglu H , Brockington M , Yuva Y , et al.   FKRP gene mutations cause congenital muscular dystrophy, mental retardation, and cerebellar cysts . Neurology . 2003;60:988–992
  25. Louhichi N , Triki C , Quijano-Roy S , et al.   New FKRP mutations causing congenital muscular dystrophy associated with mental retardation and central nervous system abnormalities. Identification of a founder mutation in Tunisian families . Neurogenetics . 2004;5:27–34
  26. De Paula F , Viera N , Starling A , et al.   Asymptomatic carriers for homozygous novel mutations in the FKRP gene (The other end of the spectrum) . Eur J Hum Genet . 2003;11:923–930
  27. Kondo-Iida E , Kobayashi K , Watanabe M , et al.   Novel mutations and genotype-phenotype relationships in 107 families with Fukuyama-type congenital muscular dystrophy (FCMD) . Hum Mol Genet . 1999;8:2303–2309
  28. Balci B , Uyanik G , Dincer P , et al.   An autosomal recessive limb girdle muscular dystrophy (LGMD2) with mild mental retardation is allelic to Walker-Warburg syndrome (WWS) caused by a mutation in the POMT1 gene . Neuromuscul Disord . 2005;15:271–275
  29. Haliloglu G , Gross C , Senbil N , et al.   Clinical spectrum of muscle-eye-brain disease (From the typical presentation to severe autistic features) . Acta Myol . 2004;23:137–139
  30. Michele DE , Barresi R , Kanagawa M , et al.   Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies . Nature . 2002;418:417–422
  31. Ervasti JM , Campbell KP . Membrane organization of the dystrophin-glycoprotein complex . Cell . 1991;66:1121–1131
  32. Ibraghimov-Beskrovnaya O , Ervasti JM , Leveille CJ , et al.   Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix . Nature . 1992;355:696–702
  33. Martin PT . Dystroglycan glycosylation and its role in matrix binding in skeletal muscle . Glycobiology . 2003;13:55R–66R
  34. Blake DJ , Weir A , Newey SE , et al.   Function and genetics of dystrophin and dystrophin-associated proteins in muscle . Physiol Rev . 2002;82:291–329
  35. Chiba A , Matsumura K , Yamada H , et al.   Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve alpha dystroglycan . J Biol Chem . 1997;272:2156–2162
  36. Sasaki T , Yamada H , Matsumura K , et al.   Detection of O-mannosyl glycans in rabbit skeletal muscle alpha-dystroglycan . Biochem Biophys Acta . 1998;1425:599–606
  37. Smalheiser NR , Haslam SM , Sutton-Smith M , et al.   Structural analysis of sequences O-linked to mannose reveals a novel Lewis x structure in cranin (dystroglycan) purified from sheep brain . J Biol Chem . 1998;273:23689–23703
  38. Willer T , Camern-Valero M , Tanner W , et al.   O-mannosyl glycans (From yeast to novel associations with human disease) . Curr Opin Struct Biol . 2003;13:621–630
  39. Moore SA , Saito F , Chen J , et al.   Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy . Nature . 2002;418:422–425
  40. Saito F , Moore SA , Barresi R , et al.   Unique role of dystroglycan in peripheral nerve myelination, nodal structure, and sodium channel stabilization . Neuron . 2003;38:747–758
  41. Cohn RD , Henry MD , Michele DE , et al.   Disruption of dag1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration . Cell . 2002;110:639–648
  42. Akasaka-Manya K , Manya H , Endo T . Mutations in the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect in protein O-mannosylation . Biochem Biophys Res Commun . 2003;325:75–79
  43. Ichimiya T , Manya H , Ohmae Y , et al.   The twisted abdomen phenotype of Drosophila POMT1 and POMT2 mutants coincides with their heterophilic protein O-mannosyltransferase activity . J Biol Chem . 2004;279:42638–42647
  44. Manya H , Chiba A , Yoshida A , et al.   Demonstration of mammalian protein O-mannosyltransferase activity:coexpression of POMT1 and POMT2 required for enzymatic activity . Proc Natl Acad Sci U S A . 2004;101:500–505
  45. Willer T , Prados B , Falcon-Perez JM , et al.   Targeted disruption of the Walker Warburg syndrome gene Pomt1 in mouse results in embryonic lethality . Proc Natl Acad Sci U S A . 2004;101:14126–14131
  46. Williamson RA , Henry MD , Daniels KJ , et al.   Dystroglycan is essential for early embryonic development:disruption of Reichert’s membrane in Dag-1 null mice . Hum Mol Genet . 1997;6:831–841
  47. Jayasinha V , Nguyen HH , Xia B , et al.   Inhibition of dystroglycan cleavage causes muscular dystrophy in transgenic mice . Neuromuscul Disord . 2003;13:365–375
  48. Matsumoto H , Noguchi S , Sugie K , et al.   Subcellular localization of fukutin and fukutin-related protein in muscle cells . J Biochem . 2004;135:709–712
  49. Takeda S , Kondo M , Sasaki J , et al.   Fukutin is required for maintenance of muscle integrity, cortical histiogenesis and normal eye development . Hum Mol Genet . 2003;12:1449–1459
  50. Esapa CT , McIihinney RA , Blake DJ . Fukutin-related protein mutations that cause congenital muscular dystrophy result in ER-retention of the mutant protein in cultured cells . Hum Mol Genet . 2005;14:295–305
  51. Brown SC , Torelli S , Brockington M , et al.   Abnormalities in a dystroglycan expression in MDC1C and LGMD2I muscular dystrophies . Am J Pathol . 2004;164:727–737
  52. Esko JD , Selleck SB . Order out of chaos (Assembly of ligand binding sites in heparan sulfate) . Annu Rev Biochem . 2002;71:435–471
  53. Patnaik SK , Stanley P . Mouse LARGE can modify complex N- and mucin O-glycans on alpha-dystroglycan to induce laminin binding . J Biol Chem . 2005;280:20851–20859
  54. Combs AC , Ervasti JM . Enhanced laminin binding by α-dystroglycan after enzymatic digestion . Biochem J . 2005;390:303–309
  55. Barresi R , Michele DE , Kanagawa M , et al.   LARGE can functionally bypass α-dystroglycan glycoyslation defects in distinct congenital muscular dystrophies . Nature Med . 2004;10:696–703
  56. Fujimura K , Sawaki H , Sakai T , et al.   LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE . Biochem Biophys Res Commun . 2005;329:1162–1171
  57. Grewal PK , McLaughlan JM , Moore CJ , et al.   Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies . Glycobiology . 2005;15:912–923
  58. Brockington M , Torelli S , Prandini P , et al.   Localization and functional analysis of the LARGE family of glycosyltransferases (Significance for muscular dystrophy) . Hum Mol Genet . 2005;14:657–665
  59. Zhang W , Vajsar J , Cao P , et al.   Enzymatic diagnostic test for muscle-eye-brain type congenital muscular dystrophy using commercially available reagents . Clin Biochem . 2003;36:339–344
  60. Nguyen HH , Jayasinha V , Xia B , et al.   Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in the mdx mouse . Proc Natl Acad Sci U S A . 2002;99:5616–5621

 Supported by grants from the Muscular Dystrophy Association and the National Institutes of Health (AR050202) to PTM.

PII: S1071-9091(05)00076-8

doi: 10.1016/j.spen.2005.10.003

Seminars in Pediatric Neurology
Volume 12, Issue 3 , Pages 152-158 , September 2005

Article Tools

* Image Usage & Resolution